Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Wave Life Sciences Ltd. (NASDAQ: WVE) closed at $5.37 down -0.74% from its previous closing price of $5.41. In other words, the price has decreased by -$0.74 from its previous closing price. On the day, 0.54 million shares were traded. WVE stock price reached its highest trading level at $5.52 during the session, while it also had its lowest trading level at $5.12.
Ratios:
For a deeper understanding of Wave Life Sciences Ltd.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 0.99. In the meantime, Its Debt-to-Equity ratio is 6.56 whereas as Long-Term Debt/Eq ratio is at 4.93.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on May 15, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On December 19, 2023, Leerink Partners Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $5 to $12.
On July 05, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.Raymond James initiated its Outperform rating on July 05, 2023, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 03 ’24 when Moran Kyle sold 15,630 shares for $6.17 per share. The transaction valued at 96,421 led to the insider holds 33,921 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares of WVE for $5,000,000 on Dec 11 ’23. The Director now owns 19,202,009 shares after completing the transaction at $5.00 per share. On Dec 07 ’23, another insider, GSK plc, who serves as the 10% Owner of the company, bought 3,300,000 shares for $5.00 each. As a result, the insider paid 16,500,000 and bolstered with 13,983,761 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 674831744 and an Enterprise Value of 552633344. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.06. Its current Enterprise Value per Revenue stands at 5.001 whereas that against EBITDA is -6.962.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $7.67, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is -7.83%, while the 200-Day Moving Average is calculated to be -0.72%.
Shares Statistics:
For the past three months, WVE has traded an average of 895.47K shares per day and 807950 over the past ten days. A total of 119.16M shares are outstanding, with a floating share count of 98.26M. Insiders hold about 21.23% of the company’s shares, while institutions hold 76.87% stake in the company. Shares short for WVE as of 1721001600 were 3884745 with a Short Ratio of 4.02, compared to 1718323200 on 3117112. Therefore, it implies a Short% of Shares Outstanding of 3884745 and a Short% of Float of 6.64.
